Please login to the form below

Not currently logged in
Email:
Password:

inVentiv Health wins Pfizer account

Will be tasked with managing the pharma firm’s global clinical services

inVentiv HealthUS pharmaceutical services organisation inVentiv Health has been named by Pfizer as its preferred provider for global clinical services.

The company will oversee Pfizer's sourcing strategy for the clinical operations of all its worldwide business until June 2019, at which point Pfizer may extend the deal for a further two years.

President of the clinical division at inVentiv Health Dr Michael McKelvy, said: "Complex science and challenging marketplace dynamics are driving the need for new, accelerated approaches to clinical development."

He added: "This agreement is an indication that our leading full-service clinical offerings are value-enhancing and scalable. We designed this approach to deliver patient-centric outcomes in an increasingly competitive environment."

As a result of winning Pfizer's clinical operations account, inVentiv Health expanded its clinical operations, with a focus on oncology, pain, neuroscience and respiratory therapeutic areas as well as data and technology-driven efficiency measures.

Gregory Skalicky, chief commercial officer of inVentiv Health's clinical division, said: "The expansion of our relationship under this new preferred provider status will allow us to continue to seamlessly orchestrate our full suite of clinical solutions.

"We're committed to realising improved efficiencies in support of Pfizer's clinical development activities."

Article by
Rebecca Clifford

29th June 2016

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Havas Life Medicom

We’re a specialist-led, unified communications agency delivering connected healthcare communications, informed through fresh insights, smart thinking and inspired ideas. Our...

Latest intelligence

Virtual Hackathon on Healthcare Innovation: a Customer Story
How participants from 9 different countries in the APAC region were brought together to participate in a pharmaceutical company-wide 3-day virtual "hackathon," with spectacular results....
OPEN Health at the World Orphan Drug Conference USA
Our Director of Rare Disease, Gavin Jones looks forward to his conversation with Emily Crossle & Betsy Bogard at #WODCUSA2020 !...
Can involving patients in design transform the clinical trial experience?
While the research space is a heavily regulated environment and there are rules that we must abide by, this doesn’t mean clinical study materials have to be ‘boring’ or the...

Infographics